Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial

Yongtong Zhan,Shuqing Liang,Zecheng Yang,Qichen Luo,Shuai Li,Jiamin Li,Zhaojia Liang,Yalan Li
DOI: https://doi.org/10.1186/s12876-022-02467-8
2022-08-21
BMC Gastroenterology
Abstract:Painless gastrointestinal endoscopy is widely used for the diagnosis and treatment of digestive diseases. At present, propofol is commonly used to perform painless gastrointestinal endoscopy, but the high dose of propofol often leads to a higher incidence of cardiovascular and respiratory complications. Studies have shown that the application of propofol combined with ketamine in painless gastrointestinal endoscopy is beneficial to reduce the dosage of propofol and the incidence of related complications. Esketamine is dextrorotatory structure of ketamine with a twice as great anesthetic effect as normal ketamine but fewer side effects. We hypothesized that esketamine may reduce the consumption of propofol and to investigate the safety of coadministration during gastrointestinal endoscopy.
gastroenterology & hepatology
What problem does this paper attempt to address?